<DOC>
	<DOC>NCT00193674</DOC>
	<brief_summary>The purpose of this clinical study is to demonstrate the shift from inflammatory cytokines to non-inflammatory cytokines in women suffering from habitual abortion treated with dydrogesterone (Duphaston).</brief_summary>
	<brief_title>Habitual Abortion Study: Oral Dydrogesterone Treatment During Pregnancy in Women With Recurrent Miscarriage</brief_title>
	<detailed_description />
	<mesh_term>Abortion, Spontaneous</mesh_term>
	<mesh_term>Abortion, Habitual</mesh_term>
	<mesh_term>Dydrogesterone</mesh_term>
	<criteria>Inclusion Criteria Women with a history of idiopathic recurrent miscarriage, based on a documented history of at least three spontaneous consecutive miscarriages before 20 weeks gestation with the same partner Exclusion Criteria Any verifiable cause of the recurrent miscarriages apart from luteal phase defect (e.g. systemic lupus erythematosus [SLE], infections with chlamydia or mycoplasma) Any gynecological neoplasias or anatomical abnormalities that oppose pregnancy Concurrent infertility treatment/superovulation protocol</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Pregnancy</keyword>
	<keyword>Immunology</keyword>
	<keyword>Unexplained recurrent miscarriage</keyword>
</DOC>